FOR IMMEDIATE RELEASE:

Quincy Bioscience to Present at Biotechnology Industry Organization Convention

MADISON, Wisconsin (February 14, 2006)

Quincy Bioscience will be giving a presentation at the 2006 Biotechnology Industry Organization Convention held in Chicago, IL. Speaking on behalf of Quincy Bioscience will be Mark Underwood the President of Quincy Bioscience and one of the founders of the company. Quincy is dedicated to developing therapeutics to fight the diseases of aging including Alzheimer's, Parkinson's and other related neurodegenerative conditions.

The presentation will cover the scientific advancements that they company has made with their jellyfish derived technology (aequorin) and also its impact on their business development and corporate growth. The company is seeking additional equity financing to further develop its therapeutic compound to address the imbalance of calcium ions related to aging disorders.

It is the goal of Quincy Bioscience to apply the technology developed from the aequorin molecule to develop products that fight the diseases of aging. Many different conditions are related to the disruption of calcium homeostasis.

For more information, contact Mark Underwood at munderwood@quincybioscience.com or toll-free at 877-677-8652.